Ankin Law News
Friday, May 10, 2013: Josh Rudofi will be filing an Appellate Brief in Dig Right In Landscaping v. Jose Nunez on behalf of Jose Nunez.
Wednesday, April 24, 2013: Scott Goldstein will be speaking as a guest lecturer at John Marshall Law School in the Workers Compensation class.
Wednesday, April 17, 2013: Josh Rudolfi attended Artex Risk Solutions Mock Trial at The Witt. (read more...)
November 30, 2012: Scott Goldstein of Ankin Law Office
was highlighted in a "Making Chicago Great" feature
on WCIU Channel 26 in Chicago.
November, 2012: A client of Howard Ankin knitted him a
blanket as a special thank you after a multiple
6 figure settlement.
RECENT BLOG POSTS
While there are a few hardy souls who bike to work all winter long, spring...
Have you ever been told you are not allowed to discuss your salary with co-workers?...
Under a new law, effective January 1st of this year, inline skaters and roller bladers...
Illinois Raptiva Lawsuit Attorneys
Chicago Unsafe Pharmaceutical Drug Lawyers
Raptiva is used to treat psoriasis and has been associated with serious side effects, including bacterial, viral and fungal infections affecting the central nervous system. The Chicago Raptiva lawsuit attorneys at Ankin Law Offices have significant experience representing clients in product liability lawsuits, including class action cases and unsafe pharmaceutical litigation. If you or someone you love has suffered serious side effects or health problems as a result of taking Raptiva, our skilled Illinois unsafe pharmaceutical attorneys can help you with any product liability lawsuit you may have.
What is Raptiva?
Raptiva is an injectable drug manufactured by Genentech that was approved by the FDA on in 2003 for the treatment of moderate to severe plaque psoriasis.
What Are the Reported Problems With Raptiva?
Side effects associated with Raptiva are common and can be severe. Raptiva side effects include headache, fever, nausea, chills and muscle pain or weakness. These symptoms usually occurred within two days of taking the first dose of the drug. Raptiva also includes the risk of bacterial, viral and fungal infections affecting the central nervous system, known as PML, recurrent and severe arthritis, lymphoma, Guillain-Barre Syndrome and facial palsy.
What Is the Status of Raptiva?
In 2005, Raptiva’s label was updated to include warnings that the drug carries potential risk of hemolytic anemia, tuberculous pneumonia, blood poisoning and flesh eating bacteria. Genetech added new safety information to the drug’s label to warn of the potential risks of PML, recurrent and severe arthritis, lymphoma, Guillain-Barre Syndrome and facial palsy.
In 2008, the U.S. Food and Drug Administration (FDA) issued a black box warning for Raptiva requiring its manufacturer to include warnings on the drug’s labels informing patients of the risks of life-threatening infections such as PML. In 2009, following the deaths of three patients from PML, the FDA issued a Public Health Advisory to patients and physicians and Genentech pulled the drug from the U.S. market. Since Raptiva’s side effects can manifest themselves over time, Raptiva lawsuits continue to be filed.
If you or a loved one has suffered severe side effects or other serious infections as a result of taking Raptiva, contact the knowledgeable Illinois Raptiva lawsuit attorneys at Ankin Law Offices to schedule a free consultation to discuss a possible Raptiva personal injury lawsuit.
You Might Also Be Interested In: